BARCLAYS PLC - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 53 filers reported holding NEON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$13,000
-23.5%
4,749
-67.1%
0.00%
Q4 2019$17,000
+41.7%
14,414
+100.9%
0.00%
Q3 2019$12,000
-76.9%
7,175
-35.7%
0.00%
Q2 2019$52,000
-32.5%
11,155
-5.9%
0.00%
Q1 2019$77,000
+755.6%
11,856
+578.6%
0.00%
Q4 2018$9,000
-74.3%
1,747
-57.5%
0.00%
Q3 2018$35,0004,1090.00%
Other shareholders
NEON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$16,756,0009.49%
MYDA Advisors LLC 155,000$267,0000.12%
Endurant Capital Management LP 193,052$332,0000.12%
FNY Investment Advisers, LLC 210,000$361,0000.11%
HARVARD MANAGEMENT CO INC 505,871$870,0000.08%
Alambic Investment Management, L.P. 25,800$44,0000.03%
OXFORD ASSET MANAGEMENT LLP 209,307$360,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 155,619$268,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 116,600$201,0000.00%
Tower Research Capital LLC (TRC) 14,371$25,0000.00%
View complete list of NEON THERAPEUTICS INC shareholders